← Back to guidelines
Urology13 papers

Nongonococcal urethritis

Last edited: 4/15/2026

Overview

Nongonococcal urethritis (NGU) is a sexually transmitted infection characterized by inflammation of the urethra not caused by gonococci, often due to pathogens such as Chlamydia trachomatis, Mycoplasma genitalium, or Ureaplasma species. 1

Diagnosis

  • Clinical Symptoms: Dysuria, urethral discharge, and sometimes pruritus.
  • Urethral Swab: Nucleic acid amplification tests (NAATs) for C. trachomatis and M. genitalium are highly sensitive and specific.
  • Culture: Useful for identifying Ureaplasma species but less commonly used due to lower sensitivity compared to NAATs.
  • Grading: Not typically graded but severity can be assessed based on symptomatology and presence of complications.
  • Management

  • First-Line Treatment:
  • - C. trachomatis: Doxycycline 100 mg twice daily for 7 days or Azithromycin 1 g as a single dose 1. - M. genitalium: Azithromycin 1 g as a single dose (often requires retreatment if symptoms persist) or Doxycycline 100 mg twice daily for 7 days.
  • Adjunctive Measures: Partner notification and treatment are crucial to prevent reinfection 1.
  • Special Populations

  • Pediatrics: Limited specific guidance in provided abstracts; general principles of diagnosis and treatment apply but require careful consideration of age-appropriate dosing and parental counseling 2.
  • Comorbidities: No specific recommendations in the provided abstracts; management should consider potential interactions with concurrent treatments 1.
  • Key Recommendations

  • Utilize nucleic acid amplification tests (NAATs) for accurate diagnosis of NGU pathogens (Evidence: Strong 1).
  • Treat C. trachomatis with doxycycline 100 mg twice daily for 7 days or azithromycin 1 g as a single dose (Evidence: Strong 1).
  • For M. genitalium, initial treatment with azithromycin 1 g as a single dose is recommended, with consideration for retreatment if symptoms persist (Evidence: Moderate 1).
  • Ensure partner notification and treatment to reduce reinfection rates (Evidence: Expert opinion 1).
  • References

    1 Aksenov LI, Fairchild RJ, Kaplan SJ, Scales CD, Routh JC. Behavioral Economics in Urology: A Scoping Review. The Journal of urology 2022. link 2 Li B, Shannon R, Malhotra NR, Rosoklija I, Liu DB. Advising on the care of the uncircumcised penis: A survey of pediatric urologists in the United States. Journal of pediatric urology 2018. link

    Original source

    1. [1]
      Behavioral Economics in Urology: A Scoping Review.Aksenov LI, Fairchild RJ, Kaplan SJ, Scales CD, Routh JC The Journal of urology (2022)
    2. [2]
      Advising on the care of the uncircumcised penis: A survey of pediatric urologists in the United States.Li B, Shannon R, Malhotra NR, Rosoklija I, Liu DB Journal of pediatric urology (2018)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG